By Payer Type

Medicare (Part B. Clinical Lab Fee Schedule) Market Analysis

Cross-industry research covering Medicare (Part B. Clinical Lab Fee Schedule) across 1 market reportspanning Pharmaceuticals & Diagnostics.

1 Reports

1 Industries

Reports Covering Medicare (Part B. Clinical Lab Fee Schedule)

Hematology Analyzers and Reagents Market to Reach USD 8.9 Billion by 2033 at 6.4% CAGR

Pharmaceuticals & Diagnostics·Market: USD 5.4 Billion (2025)·CAGR: 6.4%

CMS Medicare Part B reimburses CBC under the Clinical Laboratory Fee Schedule (CLFS); the Protecting Access to Medicare Act (PAMA) methodology revisions continue to exert downward pressure on CLFS rates, making this the most price-pressured payer segment in the U.S. market.

18%

Market Share

4.9%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments